Vogler S - Search Results

1

Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines.

Vogler S, Zimmermann N, Haasis MA, Knoll V, Espin J, Mantel-Teeuwisse AK, Panteli D, Suleman F, Wirtz VJ, Babar ZU. Vogler S, et al. J Pharm Policy Pract. 2024 Apr 24;17(Suppl 1):2335492. doi: 10.1080/20523211.2024.2335492. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 38757122 Free PMC article.

2

Differences in external price referencing in Europe: a descriptive overview.

Leopold C, Vogler S, Mantel-Teeuwisse AK, de Joncheere K, Leufkens HG, Laing R. Leopold C, et al. Among authors: vogler s. Health Policy. 2012 Jan;104(1):50-60. doi: 10.1016/j.healthpol.2011.09.008. Epub 2011 Oct 19. Health Policy. 2012. PMID: 22014843

3

Pharmaceutical policies in European countries in response to the global financial crisis.

Vogler S, Zimmermann N, Leopold C, de Joncheere K. Vogler S, et al. South Med Rev. 2011 Dec;4(2):69-79. doi: 10.5655/smr.v4i2.1004. Epub 2011 Dec 2. South Med Rev. 2011. PMID: 23093885 Free PMC article.

4

Discounts and rebates granted to public payers for medicines in European countries.

Vogler S, Zimmermann N, Habl C, Piessnegger J, Bucsics A. Vogler S, et al. South Med Rev. 2012 Jul;5(1):38-46. Epub 2012 Jul 23. South Med Rev. 2012. PMID: 23093898 Free PMC article.

5

Impact of external price referencing on medicine prices - a price comparison among 14 European countries.

Leopold C, Mantel-Teeuwisse AK, Seyfang L, Vogler S, de Joncheere K, Laing RO, Leufkens H. Leopold C, et al. Among authors: vogler s. South Med Rev. 2012 Dec;5(2):34-41. Epub 2012 Dec 27. South Med Rev. 2012. PMID: 23532710 Free PMC article.

6

The role of discounts and loss leaders in medicine procurement in Austrian hospitals - a primary survey of official and actual medicine prices.

Vogler S, Zimmermann N, Habl C, Mazag J. Vogler S, et al. Cost Eff Resour Alloc. 2013 Jul 4;11(1):15. doi: 10.1186/1478-7547-11-15. Cost Eff Resour Alloc. 2013. PMID: 23826758 Free PMC article.

7

Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries.

Leopold C, Mantel-Teeuwisse AK, Vogler S, de Joncheere K, Laing RO, Leufkens HG. Leopold C, et al. Among authors: vogler s. Health Policy. 2013 Oct;112(3):209-16. doi: 10.1016/j.healthpol.2013.08.012. Epub 2013 Sep 8. Health Policy. 2013. PMID: 24060335

8

Personalised medicine as a challenge for public pricing and reimbursement authorities – A survey among 27 European countries on the example of trastuzumab.

Leopold C, Vogler S, Habl C, Mantel-Teeuwisse AK, Espin J. Leopold C, et al. Among authors: vogler s. Health Policy. 2013 Dec;113(3):313-22. doi: 10.1016/j.healthpol.2013.09.018. Health Policy. 2013. PMID: 24409503

9

Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses.

Leopold C, Zhang F, Mantel-Teeuwisse AK, Vogler S, Valkova S, Ross-Degnan D, Wagner AK. Leopold C, et al. Among authors: vogler s. Int J Equity Health. 2014 Jul 25;13:53. doi: 10.1186/1475-9276-13-53. Int J Equity Health. 2014. PMID: 25062657 Free PMC article.

10

Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries.

Leopold C, Mantel-Teeuwisse AK, Vogler S, Valkova S, de Joncheere K, Leufkens HG, Wagner AK, Ross-Degnan D, Laing R. Leopold C, et al. Among authors: vogler s. Bull World Health Organ. 2014 Sep 1;92(9):630-640D. doi: 10.2471/BLT.13.129114. Epub 2014 Jun 16. Bull World Health Organ. 2014. PMID: 25378754 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters